All Insiders Activity for Actinium Pharmaceuticals Inc. (Delaware) (ATNM)

$ 11.19   0.30 (+2.75%) Volume: 260.66k 1:00 PM EST Nov 27, 2020
After Hours:  $ 11.45   0.26 (+2.32%) Volume: 112 4:53 PM EST Nov 27, 2020
Name: Transaction:
Date Name: Shares Transaction Value
07/12/19 Sandesh Seth,
Director, Chairman & CEO
1,500,000 Acqusition at $0.232 per share. $348,000
07/12/19 Richard I. Steinhart,
250,000 Acqusition at $0.232 per share. $58,000
07/12/19 Dale L. Ludwig,
Chief Scientific Officer
400,000 Acqusition at $0.232 per share. $92,800
07/12/19 Steven O'Loughlin,
Principal Financial Officer
400,000 Acqusition at $0.232 per share. $92,800
07/12/19 Mark S. Berger,
Chief Medical Officer
400,000 Acqusition at $0.232 per share. $92,800
07/12/19 Jeffrey W. Chell,
250,000 Acqusition at $0.232 per share. $58,000
07/12/19 Anil Kapur,
Chief Commercial Officer
400,000 Acqusition at $0.232 per share. $92,800
07/12/19 Ajit S. Shetty,
250,000 Acqusition at $0.232 per share. $58,000
07/12/19 C. David Nicholson,
250,000 Acqusition at $0.232 per share. $58,000
03/05/19 Mark S. Berger,
Chief Medical Officer
3,500 Option Exercise at $0.60 per share. $2,100
02/21/19 Sandesh Seth,
Director, Chairman & CEO
8,125 Option Exercise at $0.60 per share. $4,875
12/10/18 Sandesh Seth,
Director, Chairman & CEO
10,000 Buy at $0.4372 per share. $4,372
12/10/18 Steven O'Loughlin,
Principal Financial Officer
10,000 Buy at $0.435 per share. $4,350
11/19/18 Dale L. Ludwig,
Chief Scientific Officer
10,000 Buy at $0.4499 per share. $4,499
07/17/18 Sandesh Seth,
Director, Chairman & CEO
10,000 Buy at $0.79 per share. $7,900
  Page 1 of 6   Next Page
View Section 16 Filings (Forms 3,4,5) for ATNM Insider Summary For ATNM